180 related articles for article (PubMed ID: 1708834)
1. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.
Wellstein A; Zugmaier G; Califano JA; Kern F; Paik S; Lippman ME
J Natl Cancer Inst; 1991 May; 83(10):716-20. PubMed ID: 1708834
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals.
Zugmaier G; Lippman ME; Wellstein A
J Natl Cancer Inst; 1992 Nov; 84(22):1716-24. PubMed ID: 1279186
[TBL] [Abstract][Full Text] [Related]
3. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
[TBL] [Abstract][Full Text] [Related]
4. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
[TBL] [Abstract][Full Text] [Related]
5. Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro.
Herbert JM; Cottineau M; Driot F; Pereillo JM; Maffrand JP
Biochem Pharmacol; 1988 Nov; 37(22):4281-8. PubMed ID: 2461712
[TBL] [Abstract][Full Text] [Related]
6. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.
Pluda JM; Shay LE; Foli A; Tannenbaum S; Cohen PJ; Goldspiel BR; Adamo D; Cooper MR; Broder S; Yarchoan R
J Natl Cancer Inst; 1993 Oct; 85(19):1585-92. PubMed ID: 7692072
[TBL] [Abstract][Full Text] [Related]
7. The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo.
Yunmbam MK; Wellstein A
Oncol Rep; 2001; 8(1):161-4. PubMed ID: 11115590
[TBL] [Abstract][Full Text] [Related]
8. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
Bagheri-Yarmand R; Kourbali Y; Mabilat C; Morère JF; Martin A; Lu H; Soria C; Jozefonvicz J; Crépin M
Br J Cancer; 1998 Jul; 78(1):111-8. PubMed ID: 9662260
[TBL] [Abstract][Full Text] [Related]
9. FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation.
Jouanneau J; Moens G; Montesano R; Thiery JP
Growth Factors; 1995; 12(1):37-47. PubMed ID: 8527162
[TBL] [Abstract][Full Text] [Related]
10. Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors.
Zugmaier G; Favoni R; Jaeger R; Rosen N; Knabbe C
Ann N Y Acad Sci; 1999; 886():243-8. PubMed ID: 10667230
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.
McLeskey SW; Zhang L; Kharbanda S; Kurebayashi J; Lippman ME; Dickson RB; Kern FG
Breast Cancer Res Treat; 1996; 39(1):103-17. PubMed ID: 8738610
[TBL] [Abstract][Full Text] [Related]
12. Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate.
Parker BW; Swain SM; Zugmaier G; DeLap RL; Lippman ME; Wellstein A
J Natl Cancer Inst; 1993 Jul; 85(13):1068-73. PubMed ID: 7685831
[TBL] [Abstract][Full Text] [Related]
13. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
14. Experimental evidence for FGF-1 control of blastema cell proliferation during limb regeneration of the amphibian Pleurodeles waltl.
Zenjari C; Boilly-Marer Y; Desbiens X; Oudghir M; Hondermarck H; Boilly B
Int J Dev Biol; 1996 Oct; 40(5):965-71. PubMed ID: 8946244
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of breast cancer in nude mouse model by anti-angiogenesis.
Yunmbam MK
Oncol Rep; 1998; 5(6):1431-7. PubMed ID: 9769382
[TBL] [Abstract][Full Text] [Related]
16. A novel role of fibroblast growth factor-2 and pentosan polysulfate in the pathogenesis of intestinal bleeding in mice.
Jerebtsova M; Wong E; Przygodzki R; Tang P; Ray PE
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H743-50. PubMed ID: 17071728
[TBL] [Abstract][Full Text] [Related]
17. Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
Taylor WR; Greenberg AH; Turley EA; Wright JA
Exp Cell Res; 1993 Feb; 204(2):295-301. PubMed ID: 8440326
[TBL] [Abstract][Full Text] [Related]
18. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
[TBL] [Abstract][Full Text] [Related]
20. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
Talarico D; Basilico C
Mol Cell Biol; 1991 Feb; 11(2):1138-45. PubMed ID: 1990270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
